Related Experiment Video
Updated: Jul 15, 2026

06:28
Anterior Cruciate Ligament Transection and Synovial Fluid Lavage in a Rodent Model to Study Joint Inflammation and Posttraumatic Osteoarthritis
Published on: September 2, 2025
Sarcomatous transformation in diaphyseal aclasis
1Department of Diagnostic Radiology, Changi General Hospital, Singapore.
Australasian Radiology
|April 11, 2007
Summary
Multiple hereditary exostosis causes multiple bone tumors. Imaging like CT and MRI helps diagnose this condition and detect malignant transformation into chondrosarcoma, distinguishing it from benign growths.
Area of Science:
- Orthopedics
- Radiology
- Oncology
Background:
- Multiple hereditary exostosis (MHE), also known as diaphyseal aclasis, is a genetic disorder.
- It is characterized by the formation of numerous osteochondromas, which are benign bone tumors.
- A significant concern in MHE is the potential for malignant transformation into chondrosarcoma.
Purpose of the Study:
- To review the diagnostic role of imaging modalities in multiple hereditary exostosis.
- To highlight the importance of distinguishing malignant transformation from pseudotumors.
- To emphasize the features of sarcomatous change detectable by advanced imaging.
Main Methods:
- Review of radiographic and computed tomography (CT) findings in MHE.
- Analysis of magnetic resonance imaging (MRI) characteristics in differentiating malignancy.
- Correlation of imaging findings with clinical presentation and pathological outcomes.
Main Results:
- Radiographs and CT scans are crucial for diagnosing MHE and identifying osteochondromas.
- MRI is effective in visualizing sarcomatous changes within the cartilaginous cap of osteochondromas.
- MRI aids in differentiating true malignancy (chondrosarcoma) from benign pseudotumors.
Conclusions:
- Accurate diagnosis of MHE relies on a combination of clinical evaluation and advanced imaging.
- Early detection of malignant transformation through MRI is critical for patient management.
- Distinguishing between chondrosarcoma and pseudotumors using MRI improves treatment strategies.
